← FDA Drug Approvals (Drugs@FDA)
UBROGEPANT
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABORATORIES PRIVATE LIMITED · Approved 2026-06-24
Drug application
- FDA Application #
ANDA219218- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- UBROGEPANT
- Generic name
- Ubrogepant
- Active ingredients
- UBROGEPANT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MSN LABORATORIES PRIVATE LIMITED
- First approval
- 2026-06-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown